Mathoulin-Portier MP - Search Results

1

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples.

Monges GM, Mathoulin-Portier MP, Acres RB, Houvenaeghel GF, Giovannini MF, Seitz JF, Bardou VJ, Payan MJ, Olive D. Monges GM, et al. Among authors: mathoulin portier mp. Am J Clin Pathol. 1999 Nov;112(5):635-40. doi: 10.1093/ajcp/112.5.635. Am J Clin Pathol. 1999. PMID: 10549250

2

[Pancreatic and duodenal somatostatinoma. Two clinico-pathologic entities].

Mathoulin-Portier MP, Payan MJ, Monges G, Penault-Llorca F, Barthet M, Sastre B, Giovannini M, Delpero JR, Hassoun J. Mathoulin-Portier MP, et al. Ann Pathol. 1996 Sep;16(4):299-302. Ann Pathol. 1996. PMID: 9172623 French.

3

Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3.

Jacquemier J, Mathoulin-Portier MP, Valtola R, Charafe-Jauffret E, Geneix J, Houvenaeghel G, Puig B, Bardou VJ, Hassoun J, Viens P, Birnbaum D. Jacquemier J, et al. Among authors: mathoulin portier mp. Int J Cancer. 2000 Jan 20;89(1):69-73. doi: 10.1002/(sici)1097-0215(20000120)89:1<69::aid-ijc11>3.0.co;2-m. Int J Cancer. 2000. PMID: 10719733 Free article.

4

Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation.

Braud AC, Mathoulin Portier MP, Bardou VJ, Bertucci F, Gravis G, Camerlo J, Begue M, Houvenaeghel G, Maraninchi D, Jacquemier J, Viens P. Braud AC, et al. Among authors: mathoulin portier mp. Bone Marrow Transplant. 2002 May;29(9):753-7. doi: 10.1038/sj.bmt.1703540. Bone Marrow Transplant. 2002. PMID: 12040472

5

Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin.

Mathoulin-Portier MP, Viens P, Cowen D, Bertucci F, Houvenaeghel G, Geneix J, Puig B, Bardou VJ, Jacquemier J. Mathoulin-Portier MP, et al. Oncol Rep. 2000 May-Jun;7(3):675-80. doi: 10.3892/or.7.3.675. Oncol Rep. 2000. PMID: 10767389

6

Peritumoral vascular invasion in women with node-negative breast cancer, receiving no adjuvant therapy.

Mathoulin-Portier MP, Meynard P, Charton-Bain MC, Escoute M, Bardou VJ, Puig B, Viens P, Cowen D, Houvenaeghel G, Hassoun J, Jacquemier J. Mathoulin-Portier MP, et al. Anticancer Res. 1999 Jan-Feb;19(1B):843-7. Anticancer Res. 1999. PMID: 10216503

7

[Mammary carcinoma arising in microglandular adenosis: a case report].

Charafe-Jauffret E, Jacquemier J, Lelong B, Meynard P, Mathoulin-Portier MP, Houvenhaegel G, Hassoun J. Charafe-Jauffret E, et al. Among authors: mathoulin portier mp. Ann Pathol. 2001 Oct;21(5):435-8. Ann Pathol. 2001. PMID: 11852363 French.

8

Malignant mullerian mixed tumor of the uterine cervix with adenoid cystic component.

Mathoulin-Portier MP, Penault-Llorca F, Labit-Bouvier C, Charafe E, Martin F, Hassoun J, Jacquemier J. Mathoulin-Portier MP, et al. Int J Gynecol Pathol. 1998 Jan;17(1):91-2. doi: 10.1097/00004347-199801000-00018. Int J Gynecol Pathol. 1998. PMID: 9475200

9

PS2 expression in BRCA1-associated breast cancers.

Charafe-Jauffre E, Eisinger F, Mathoulin-Portier MP, Sobol H, Jacquemier J. Charafe-Jauffre E, et al. Among authors: mathoulin portier mp. Anticancer Res. 2001 Jul-Aug;21(4B):2877-81. Anticancer Res. 2001. PMID: 11712780

10

[Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution].

Charafe E, Penault-Llorca F, Mathoulin-Portier MP, Bladou F, Delpéro JR, Prime-Guitton C, Vieillefond A, Xerri L, Hassoun J. Charafe E, et al. Among authors: mathoulin portier mp. Ann Pathol. 1997 Dec;17(6):400-2. Ann Pathol. 1997. PMID: 9526627 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page